Ben Hargreaves speaks to Elsevier about the launch of its latest tools to improve access to information on rare diseases, such as through short-form video and through a newly launched journ
Biological systems are hugely complex, with a staggering number of pathways interacting every millisecond. The downstream effects of just one biological change are enormous.
Denmark's Lundbeck has signed an agreement with information business Elsevier, that aims to help organise the masses of scientific data it has available, and make drug research more product
A groundbreaking analysis of how well animal studies predict human safety will lead to reduced animal testing and better clinical results for patients, it is hoped.
Japan’s Taisho Pharmaceutical looks like it could be heading into private ownership, thanks to a management buyout offer (MBO) that could value the company at almost $5 bi
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio